CT SB00300

Replaces "supervising physician" language with "collaborating physician" throughout Connecticut medical practice statutes, effective October 1, 2018, shifting physician assistant oversight from supervision to collaboration model.

Defines "collaboration" as a continuous process where physician assistants and physicians jointly contribute to patient care, including consultation, referral, outcome review, and written agreement on controlled substance prescribing authority for schedule II and III drugs.

Expands physician assistant prescribing authority to include schedule II and III controlled substances in all settings without requiring physical presence of the collaborating physician, contingent on written physician approval.

Eliminates the previous limitation capping supervising physicians to six full-time physician assistants and removes requirement that physician assistants have a "clearly identified" single supervising physician.

Adds physician assistant representation to the Connecticut Medical Examining Board (one member) and creates new statutory exemption allowing physician assistants to practice under collaborative arrangement rather than under supervision.